Northern Exposure PR

Our Clients

Client News

04/01/2019 Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities

12/02/2019 SGS to Conduct its First Malaria Human Challenge Trial in Belgium

13/02/2019 Catalent Names Alessandro Maselli President and Chief Operating Officer

18/02/2019 Catalent Receives P&G External Business Partner of the Year Award

21/02/2019 Catalent Appoints Kay Schmidt to Executive Leadership Team to Lead New Technical Operations Organization

07/03/2019 Catalent Invests Over $27 Million to Commercialize Zydis® Ultra, a Next Generation Oral Disintegrating Tablet

12/03/2019 Successful Phase 2 Clinical Trial Results with Novel Influenza Vaccine Validate SGS’s H3N2 Challenge Agent (A/Belgium)

14/03/2019 Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan

21/03/2019 Catalent Signs CEO Action for Diversity and Inclusion Pledge

01/04/2019 Triphase Accelerator Initiates Phase 1 Clinical Trial of TRPH-222 in B-cell Lymphoma

04/04/2019 Catalent Expands OptiMelt® Hot Melt Extrusion Capabilities at Somerset Drug Development Center of Excellence

10/04/2019 Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA

11/04/2019 Catalent Celebrates Opening of Second Shanghai Facility to Optimize Global and Local Clinical Supply Solutions for China

15/04/2019 Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

23/04/2019 Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan

23/04/2019 Catalent Invests $14 Million at its Eberbach, Germany Softgel Facility

25/04/2019 Catalent Collaborates with MGB Biopharma to Provide Accelerated Formulation and Supply Services for Phase 2 Clinical Trial Materials

30/04/2019 SGS Implements Veeva Vault Clinical Trial Management System Across its Global Network

07/05/2019 Catalent Receives RoSPA Silver Award for its Health and Safety Practices

07/05/2019 SGS Recognized at 2019 CRO Leadership Awards for Capabilities, Compatibility, Quality, Expertise and Reliability

09/05/2019 Catalent Achieves Global ISO Accreditation

20/05/2019 Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion

23/05/2019 Catalent to Launch OneBio Suite for Integrated Biologics Development, Manufacturing and Supply at BIO International 2019

04/06/2019 Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site

17/06/2019 IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases

19/06/2019 Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy

09/07/2019 Catalent Extends Global Commercial Spray Drying Capabilities in Europe

16/07/2019 Catalent Biologics Announces Agreement to Provide Additional Production of Approved Gene Therapy Treatment for Spinal Muscular Atrophy

30/07/2019 Cambrex to Double Size of Edinburgh Solid Form Screening Facility

07/08/2019 Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash

23/08/2019 SGS Life Sciences Shortlisted as Finalist in 2019 Clinical Research News European Innovations Awards

05/09/2019 Catalent to Open New Clinical Supply Facility in San Diego

12/09/2019 Catalent Announces the Appointment of David Schaffer to Biologics Advisory Board

17/09/2019 SGS Appoints Steven Thys as Director of Global Clinical Operations

24/09/2019 Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone

02/10/2019 IDEXX Water Appoints Fisher Scientific channel, part of Thermo Fisher Scientific, as Distributor of Microbiology Testing Products in the EMEA Region for Industrial Markets

03/10/2019 Catalent Appoints Dr. Guy Dewil as General Manager of its Clinical Supply Facility in Schorndorf, Germany

Healthcare Estates

October 8 – 9, 2019

Manchester, UK

CPhI Worldwide

November 5 – 7, 2019

Frankfurt, Germany